Orthopaedic Research UK (ORUK) is offering up to £100k through the Ronald Furlong Fund to support early‑stage startups working on practical, evidence‑based solutions in musculoskeletal health.
Named in honour of the charity’s founder, who combined successful careers as an orthopaedic surgeon and entrepreneur, the Fund is designed to help entrepreneurs accelerate innovative and commercially viable ideas that solve the unmet needs of society around bone, joint and muscle wellbeing.
ORUK has investments in seven early stage MSK businesses, some of whom applied through the Ronald Furlong Fund. The charity’s investments target innovations that lead to:
- Improved clinical practices and care processes, including earlier diagnosis, better decision‑making, and optimised treatment pathways; and/or
- New products, services, and technologies that can be adopted across healthcare settings and scaled to deliver long‑term social and system‑level returns.
Visit the research page on oruk.org for further information.